SYTAW yields 44444.44% · JNJ yields 2.13%● Live data
📍 SYTAW pulled ahead of the other in Year 1
Combined, SYTAW + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYTAW + JNJ for your $10,000?
Siyata Mobile Inc. develops and provides cellular-based communications platform. It develops, markets, and sells rugged handheld Push-to-Talk over Cellular smartphone devices for first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in various industries. The company also offers VK7 Vehicle Kit and Uniden UV350 4G/LTE, an in-vehicle communication devices that incorporates voice, PoC, data, fleet management solutions, and other Android based applications for professional vehicles, such as trucks, vans, buses, emergency service vehicles, and other enterprise vehicles. In addition, it provides cellular amplifiers to boost the cellular signal inside homes, buildings, and vehicles. The company offers its products under the Uniden Cellular and Siyata brand names. It serves cellular network operators and their dealers, as well as commercial vehicle technology distributors for fleets in the United States, Canada, Europe, Australia, the Middle East, and internationally. The company is headquartered in Montreal, Canada.
Full SYTAW Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.